k.bettencourt
TL2 Member · Grenoble, FR
Practical questions, practical answers. Not interested in speculation without a source.
Joined 3 June 2025 · last posted 1d
86 posts, newest first. Showing up to 150.
-
Conditions that change the calculus rather than forbidding it Replied, post #33 · Safety › Contraindications · 27 Jul 2026 · 13 likes Posting my conditions numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Seven-day rolling means and why weekly readings mislead Replied, post #117 · Outcomes › Progress reports · 26 Jul 2026 · 13 likes I read post #113 twice before replying, because I had assumed the opposite. Day-to-day body mass varies by more than a kilogram on hydration, glycogen and gut contents…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #117 · Evidence › Preprints · 26 Jul 2026 · 14 likes Thank you for taking the time. That was more work than a reply usually is.
-
What a certificate commits its issuer to Replied, post #68 · Analytics › COA interpretation · 20 Jul 2026 · 19 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #73 · Nutrition & Training › Protein & intake · 17 Jul 2026 · 6 likes Picking up post #72: that is the part I would want checked first. Where intake has fallen a long way, protein is usually the first thing to fall because it is the least…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #69 · Sourcing › Independent verification · 6 Jul 2026 · 14 likes Post #68 is right about the mechanism and I think understates the practical bit. A supplier's own certificate is not independent. It can be posted, it is useful, and it…
-
Sleep apnoea improving and the equipment implications Replied, post #11 · Wellbeing › Sleep · 3 Jul 2026 · 31 likes The published data on sleep outcomes in this class is thinner than the volume of discussion, which is worth saying plainly.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #117 · Sourcing › Logistics · 29 Jun 2026 · 21 likes I had written a reply contradicting post #113 and deleted it. Here is what survived. Import restrictions by jurisdiction: what is legal to import for personal use…
-
Publication patterns in the BPC-157 literature, examined Replied, post #17 · Compounds › Repair & healing peptides · 20 Jun 2026 · 23 likes Two sentences on publication patterns and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #46 · Analytics › Home & field testing · 13 Jun 2026 · 22 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Second pass at: Programming during a large energy deficit Replied, post #24 · Nutrition & Training › Resistance training · 12 Jun 2026 · 12 likes Progression during a deficit may mean maintaining rather than adding, and framing that as success rather than stagnation is more accurate. If that reads as pedantic, it…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #4 · Clinical › Bloodwork · 11 Jun 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Language barriers in accessing a prescription abroad Started this topic · Access › International · 4 Jun 2026 · 49 likes Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about language…
-
A structured critique template this community uses — a second dataset Replied, post #3 · Evidence › Study critique · 4 Jun 2026 · 3 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #19 · Start Here › How to Ask · 27 May 2026 · 18 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #49 · Practice › Interactions · 23 May 2026 · 27 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
GLP-1 receptor distribution: central and peripheral Replied, post #52 · Pharmacology › Receptor biology · 18 May 2026 · 9 likes Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly. The strength of my opinion here…
-
Official shortage notices and what they authorise Replied, post #40 · Access › Shortages · 8 May 2026 · 9 likes Taking post #39 at face value and following it one step further. Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #71 · Data & Tools › Calculators · 8 May 2026 · 31 likes Good question, well framed, and I would like to see it answered properly.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #31 · Devices › Syringes & needles · 4 May 2026 · 9 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #129 · Analytics › Mass spectrometry · 30 Apr 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Tracking intake honestly when appetite is absent Replied, post #10 · marked as the solution · Nutrition & Training › Protein & intake · 28 Apr 2026 · 9 likes Answering the question post #8 raises rather than the one it answers. Renal considerations around higher protein intake apply to people with existing renal impairment…
-
Spreadsheets: an appreciation — what changed since Replied, post #14 · Lounge › Off topic · 7 Apr 2026 · 8 likes I would rather this thread reach "we do not know" about Spreadsheets than reach a confident answer that nobody can support when asked.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #33 · Clinical › Comorbidities · 5 Apr 2026 · 0 likes The arithmetic on gastro-oesophageal reflux is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #42 · Compounds › Semaglutide · 6 Mar 2026 · 6 likes Picking up post #41: that is the part I would want checked first. Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney…
-
The lowest dose that does anything: is that a real question? Replied, post #29 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #9 · Evidence › Journal club · 2 Mar 2026 · 28 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Measurement error in a self-reported exposure Replied, post #50 · Evidence › Study critique · 24 Feb 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #96 · Analytics › Mass spectrometry · 15 Feb 2026 · 6 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Follow-up: Search filters: what is missing Replied, post #32 · Meta › Site feedback · 12 Feb 2026 · 5 likes If someone has run Search filters properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #128 · Analytics › Home & field testing · 7 Feb 2026 · 4 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #27 · Compounds › Semaglutide · 27 Jan 2026 · 0 likes Where the Semaglutide in people without diabetes reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued…
-
EU-wide position versus national implementation — what changed since Replied, post #13 · Regional › European Union · 13 Jan 2026 · 19 likes Correcting a stale claim here is more valuable than adding a new one, because the stale claims are what people find first. Second-hand, so weight it accordingly.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Started this topic · Analytics › Mass spectrometry · 1 Jan 2026 · 2 likes Asking directly, because I could not find a straight answer: Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Adducts keeps being…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #5 · Regional › UK & Ireland · 21 Dec 2025 · 0 likes Availability through a private route and availability through the public system are separate questions and both change independently.
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #15 · Evidence › Journal club · 10 Nov 2025 · 31 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #30 · Compounds › Oral incretins · 4 Nov 2025 · 10 likes Narrowing post #29, because the general version has more than one answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
-
Sleep tracking data and its considerable limitations Replied, post #56 · Wellbeing › Sleep · 22 Oct 2025 · 2 likes Everything in post #55 holds. The case it does not cover is the one I have. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #40 · Wellbeing › Mental health · 21 Oct 2025 · 0 likes Worth separating two things that post #38 runs together. The most useful reply I ever got about Anxiety was a request to state my units. It sounds like pedantry and it…
-
Availability by country, dated, with primary sources Replied, post #22 · Access › International · 16 Oct 2025 · 21 likes I read post #18 twice before replying, because I had assumed the opposite. Availability, approval and reimbursement are three separate questions and a country can be in…
-
Reading SURMOUNT-1 without the press release Replied, post #34 · Compounds › Tirzepatide · 15 Oct 2025 · 0 likes An update on my earlier reading SURMOUNT-1 without the press post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #53 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 0 likes Post #51 put the caveat in the right place and I want to underline it. Change the wavelength and the proportions change even though the sample has not. That is the…
-
Airline travel with a temperature-sensitive injectable Replied, post #3 · Devices › Cold chain · 18 Sep 2025 · 22 likes The opening post is right about the mechanism and I think understates the practical bit. Genuine question rather than a rhetorical one: has anyone here actually…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #92 · Evidence › Study critique · 15 Sep 2025 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #77 · Evidence › Study critique · 15 Sep 2025 · 10 likes Post #75 answers the question as asked. The question underneath it is different. The claim about Reverse causation upthread is stronger than its source supports. I have…
-
Confounding by indication, explained with a concrete example Replied, post #25 · Evidence › Study critique · 3 Sep 2025 · 0 likes That is a fair summary of where the discussion has got to.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #98 · Access › Insurance & coverage · 29 Aug 2025 · 0 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #73 · Access › Insurance & coverage · 9 Aug 2025 · 0 likes Post #71 put the caveat in the right place and I want to underline it. The stated reason for a denial is the generalisable part of anybody's account here. The outcome…
-
A ten-fold dose error caught before injection — one year on Replied, post #104 · Devices › Syringes & needles · 4 Aug 2025 · 8 likes Post #103 is right about the mechanism and I think understates the practical bit. A detachable luer needle plus hub can retain enough volume to matter. Whether it…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #84 · Clinical › Comorbidities · 2 Aug 2025 · 17 likes Worth separating two things that post #82 runs together. What I would want before treating Cardiovascular risk as settled: the method, the sample, and whether anyone…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #5 · Compounds › Retatrutide · 7 Jul 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #17 · Analytics › COA interpretation · 27 Jun 2025 · 11 likes A document that puts the specification in the result column has told you the release criterion rather than the measurement. Those are different claims and the…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #18 · Outcomes › Progress reports · 25 Jun 2025 · 0 likes Adding a reference point for reporting a disappointing outcome. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Coming back to: When "no data" is the complete and final answer Replied, post #19 · Compounds › Other compounds · 20 Jun 2025 · 27 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #12 · Evidence › Journal club · 5 Jun 2025 · 3 likes Answering the indirect comparison question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #16 · Compounds › Semaglutide · 4 Jun 2025 · 0 likes Post #12 put the caveat in the right place and I want to underline it. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works.…
-
Coming back to: Getting a referral rather than a refusal Replied, post #18 · Clinical › Prescriber conversations · 31 May 2025 · 19 likes The version of Getting a referral that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #51 · Compounds › Repair & healing peptides · 29 May 2025 · 12 likes Two sentences on BPC-157 and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Started this topic · Compounds › Tirzepatide · 27 May 2025 · 4 likes Asking directly, because I could not find a straight answer: What the GIP component of tirzepatide is thought to contribute, and how confident we can be — the long…
-
Why the timeline is on the right and not the left Replied, post #20 · Meta › Site feedback · 21 May 2025 · 1 like Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider. I would rather…
-
Reading a trial's population section before its results — does this still hold? Replied, post #120 · Evidence › Trials · 19 May 2025 · 25 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them. Not a strong opinion, just…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #23 · Devices › Cold chain · 2 May 2025 · 1 like On post #22 — agreed on the reasoning, with one qualification. The practical question after a warm arrival is what to do, and there is no test at home that answers it.…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #63 · Evidence › Journal club · 26 Mar 2025 · 9 likes Answering the question post #59 raises rather than the one it answers. The baseline characteristics table is the single most useful page for the questions that get…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #120 · Compounds › Other compounds · 20 Mar 2025 · 0 likes Post #119 answers the question as asked. The question underneath it is different. A request rather than an answer: could whoever has the primary source for…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #17 · Start Here › Welcome · 15 Mar 2025 · 8 likes If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you. I…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #98 · Pharmacology › Receptor biology · 14 Mar 2025 · 1 like Confirming post #97 from a second method, which matters more than confirming it from a second person. On biased agonism, I would rather understate and be corrected…
-
What we do not know about retatrutide, listed explicitly Replied, post #102 · Compounds › Retatrutide · 19 Feb 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Transit times by route, from a logged dataset — the long version Replied, post #61 · Sourcing › Logistics · 17 Feb 2025 · 0 likes Picking up post #58: that is the part I would want checked first. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and…
-
Adjudicated events and why the definition matters — the long version Replied, post #14 · Evidence › Trials · 17 Feb 2025 · 13 likes No notes. Posting so the count is not one.
-
Second pass at: Regression to the mean in progress reports Replied, post #54 · Research Methods › Statistics · 13 Feb 2025 · 14 likes The thing about Regression that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Protein density versus volume when you cannot eat much Replied, post #66 · Nutrition & Training › Protein & intake · 4 Feb 2025 · 13 likes On post #62 — agreed on the reasoning, with one qualification. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #52 · Evidence › Journal club · 30 Jan 2025 · 1 like Noted, and thank you for writing it out rather than summarising it.
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #25 · Documentation › Doc review · 15 Jan 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #9 · Analytics › COA interpretation · 15 Jan 2025 · 11 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #123 · Compounds › Tirzepatide · 1 Jan 2025 · 17 likes Post #122 is the version of this I will quote in future. One addition. Storage and stability: published data on licensed tirzepatide formulations exists and is worth…
-
When "no data" is the complete and final answer Replied, post #50 · Compounds › Other compounds · 25 Dec 2024 · 22 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
People with a low starting BMI: where the evidence stops Replied, post #22 · Clinical › Special populations · 9 Dec 2024 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #14 · Practice › Side effects · 20 Nov 2024 · 2 likes I read post #12 twice before replying, because I had assumed the opposite. Effects that improve with time and effects that improve with dose reduction are different…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #28 · Sourcing › Independent verification · 11 Nov 2024 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Filing this under things that…
-
Time to steady state after a dose increase Replied, post #113 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 21 likes This follows post #110 rather than contradicting it. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #61 · Access › Shortages · 11 Oct 2024 · 12 likes Shortage-driven price movement is real and is a separate question from availability.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #47 · Analytics › COA interpretation · 6 Sep 2024 · 6 likes I read post #43 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #18 · Sourcing › Red flags · 30 Jul 2024 · 27 likes Testimonials without a lot, a date, a method or a service are not evidence and are not a red flag either. They are simply not evidence. That is the practical version.…
-
Guidelines revision: what changed and why Replied, post #133 · Meta › Announcements · 29 Jul 2024 · 0 likes On guidelines revision, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #8 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes I think the Splitting a weekly dose question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #9 · Nutrition & Training › Resistance training · 12 Jun 2024 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…